Carboplatino
Rosenbluth Lopez, Helen.
Bol. inf. medicam. (Santiago de Chile)
; 20(2/3): 2-6, dic. 2003. ilus, tab
Artículo en Español | LILACS | ID: lil-390313
Similares
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.
Investigating current practices in renal function measurement and carboplatin dosing in children with cancer - a UK perspective.
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers.
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.
Phase I study of carboplatin in combination with PM00104 (Zalypsis®) in patients with advanced solid tumors.
Electrochemical Measurement of Dopamine Release and Uptake in Zebrafish Following Treatment with Carboplatin.
Interaction of platinum agents, cisplatin, carboplatin and oxaliplatin against albumin in vivo rats and in vitro study using inductively coupled plasma-mass spectrometory.
Carboplatin dosing for adult Japanese patients.
Platinum compounds in children with cancer: toxicity and clinical management.